Nucala injection is prescribed for eosinophilic asthma and certain other conditions. It’s important to administer the injection safely and correctly so that the medication will be effective.
Hosted on MSN4mon
GSK's Respiratory Drug Nucala Meets Goal in COPD StudyGSK’s GSK phase III study evaluating its blockbuster drug Nucala (mepolizumab), an anti-IL5 biologic, for treating chronic obstructive pulmonary disease (COPD), met its primary endpoint.
Hosted on MSN1mon
FDA to review GSK’s Nucala for COPDThe US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala (mepolizumab) as an add-on maintenance treatment for chronic obstructive pulmonary ...
The US regulator has rejected GlaxoSmithKline's pulmonary disease drug Nucala in a potential new chronic obstructive pulmonary disease (COPD) use. In July, Nucala (mepolizumab), which is already ...
With competition heating up in the severe asthma category, GlaxoSmithKline has a new EU approval that it hopes will keep its Nucala drug ahead of its rivals. The European Commission has approved ...
The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with ...
The submission seeks an indication for the use of Nucala as an add-on maintenance treatment for patients with COPD with an eosinophilic phenotype. The Prescription Drug User Fee Act (PDUFA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback